Literature DB >> 12891385

SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6.

C H Zühlke1, M Spranger, S Spranger, R Voigt, M Lanz, U Gehlken, F Hinrichs, E Schwinger.   

Abstract

An expanded polyglutamine domain in the TATA-binding protein (TBP) has been described in patients with spinocerebellar ataxia type 17 (SCA17) characterized by cerebellar ataxia associated with dementia. TBP is a general transcription initiation factor that regulates the expression of most eukaryotic genes transcribed by RNA polymerase II. SCA17, as an autosomal dominantly inherited progressive neurodegenerative disorder, is caused by heterozygous expansion of a CAG repeat coding for glutamine. Alleles with 27 to a maximum of 44 glutamine residues were found as the normal range, whereas expansions above 45 repeat units were considered pathological. Here, we present a patient with a very severe phenotype with a late onset but rapidly progressing ataxia associated with dementia and homozygous 47 glutamine residues caused by an apparent partial isodisomy 6. This extraordinary case has important implications for the insights of TBP and SCA17. The expanded polyglutamine domain in both TBP copies is not correlated with embryonic death indicating that the normal function of the protein is not disrupted by this kind of mutation but may account for the dementia seen in this patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12891385     DOI: 10.1038/sj.ejhg.5201018

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.

Authors:  Shanshan Huang; Joseph J Ling; Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

2.  From normal gait to loss of ambulation in 6 months: a novel presentation of SCA17.

Authors:  R Mehanna; I Itin
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

Review 3.  Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.

Authors:  Christine Zühlke; Katrin Bürk
Journal:  Cerebellum       Date:  2007-01-19       Impact factor: 3.847

4.  Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).

Authors:  Giovanni Stevanin; Alexis Brice
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

5.  Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.

Authors:  Caterina Mariotti; Dario Alpini; Roberto Fancellu; Paola Soliveri; Marina Grisoli; Sabrina Ravaglia; Carlo Lovati; Vincenza Fetoni; Giorgio Giaccone; Alessia Castucci; Franco Taroni; Cinzia Gellera; Stefano Di Donato
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

Review 6.  Cell biology of spinocerebellar ataxia.

Authors:  Harry T Orr
Journal:  J Cell Biol       Date:  2012-04-16       Impact factor: 10.539

7.  Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.

Authors:  Christine Zühlke; Andreas Dalski; Eberhard Schwinger; Ulrich Finckh
Journal:  BMC Med Genet       Date:  2005-07-01       Impact factor: 2.103

8.  Complexity of the Genetics and Clinical Presentation of Spinocerebellar Ataxia 17.

Authors:  Suran Nethisinghe; Wei N Lim; Heather Ging; Anna Zeitlberger; Rosella Abeti; Sally Pemble; Mary G Sweeney; Robyn Labrum; Charisse Cervera; Henry Houlden; Elisabeth Rosser; Patricia Limousin; Angus Kennedy; Michael P Lunn; Kailash P Bhatia; Nicholas W Wood; John Hardy; James M Polke; Liana Veneziano; Alfredo Brusco; Mary B Davis; Paola Giunti
Journal:  Front Cell Neurosci       Date:  2018-11-23       Impact factor: 5.505

9.  Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3.

Authors:  Quan-Fu Li; Hao-Ling Cheng; Lu Yang; Yin Ma; Jing-Jing Zhao; Yi Dong; Zhi-Ying Wu
Journal:  Mol Genet Genomic Med       Date:  2020-07-09       Impact factor: 2.183

Review 10.  Mechanisms of repeat-associated non-AUG translation in neurological microsatellite expansion disorders.

Authors:  Lydia M Castelli; Wan-Ping Huang; Ya-Hui Lin; Kung-Yao Chang; Guillaume M Hautbergue
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.